OnKure Therapeutics, Inc. (OKUR) Misses Q4 EPS by 130c

OnKure Therapeutics, Inc. (NASDAQ: OKUR) reported Q4 EPS of ($1.37), $1.30 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on OnKure Therapeutics, Inc. (OKUR) click here.

You May Also Be Interested In

• Burckhardt Compression (BCHN:SW) PT Lowered to CHF620 at Berenberg
• First Merchants prices $100M subordinated notes offering at 6.75%
• AMC Entertainment prices $2.85B in new debt to refinance existing loans